Evidence map›Paper›PMID 41876803›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

Different effect of aldosterone on corrected HCO

Hiroki Yasuda, Kenichi Yokota, Takuyuki Katabami, Toshifumi Nakamura, Shoichiro Izawa, Yoichi Nozato, Norio Wada, Ryuji Okamoto, Miki Kakutani, Takashi Yoneda and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Hiroki YasudaDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Kenichi YokotaDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan. yokotak7@marianna-u.ac.jp.ORCID 0000-0001-9648-182X
Takuyuki KatabamiDivision of Metabolism and Endocrinology, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan.
Toshifumi NakamuraDivision of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Shoichiro IzawaDivision of Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago, Japan.
Yoichi NozatoDepartment of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Norio WadaDepartment of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan.
Ryuji OkamotoDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Miki KakutaniDepartment of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
Takashi YonedaDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Masanori MurakamiDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Takamasa IchijoDepartment of Diabetes and Endocrinology, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan.
Katsutoshi TakahashiDivision of Metabolism, Showa General Hospital, Kodaira, Japan.
Hiroki KobayashiDivision of Nephrology, Hypertension, and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Shintaro OkamuraDivision of Endocrinology, Tenri Hospital, Tenri, Japan.
Minemori WatanabeDepartment of Endocrinology and Diabetes, Okazaki City Hospital, Okazaki, Japan.
Daisuke TauraDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kouichi TamuraDepartment of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kaori HayashiDivision of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Mitsuhide NaruseEndocrine Center, Ijinkai Takeda General Hospital, Kyoto, Japan.
Masakatsu SoneDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary aldosteronism (PA) causes biochemical abnormalities such as hypokalemia and metabolic alkalosis. This study aimed to compare the effects of aldosterone on serum potassium and corrected bicarbonate (cHCO

Indexed as

AldosteroneBicarbonatesHyperaldosteronismAdultAgedFemaleHumansMaleMiddle AgedPotassiumAldosteroneBicarbonatesPotassiumCorrected HCO3 −HypokalemiaJPAS-IIMetabolic alkalosisPrimary aldosteronism

Identifiers

PMID41876803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.